Prostate brachytherapy is a procedure where tiny radioactive seeds are permanently placed in the prostate gland to treat prostate cancer. The implanted seeds deliver radiation that kills cancer cells in the prostate. This means there is very little radiation exposure to nearby tissues and organs and therefore very few side effects.
Prostate brachytherapy is a proven, safe, and effective technology with a long track record. It is as effective as surgery and external radiation treatments but offers several advantages; including less risk of erectile dysfunction, a better quality of life after treatment as compared to surgery and external radiation. The seed implantation procedure is completed as an outpatient in a single day, so there is no hospital stay.
The Northwell Health prostate brachytherapy team consists of national and internationally recognized leaders in prostate brachytherapy. Dr. Brett Cox, Dr. Louis Potters and Dr. Lucille Lee hold leadership and committee positions in several national organizations, including the American Society of Therapeutic Radiation Oncology (ASTRO) and the American Brachytherapy Society (ABS). They have authored more than 100 peer reviewed articles, numerous book chapters and other invited articles regarding prostate brachytherapy. They also serve as institutional investigators for several national cooperative trials involving prostate brachytherapy, are nationally and internationally invited lecturers, and serve as referees and editors for numerous academic journals.
The team is one of three centers selected to train ABS prostate fellows in prostate brachytherapy, and several regional institutions send their resident trainees to the institution to receive brachytherapy experience.